2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$45.00-$2.89 (-6.03%)
Price as of Nov 12, 2026 8:34 AM EST- $7.9BMarket Cap
- 52.49%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$45.00-$2.89 (-6.03%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $47.89 | ||
Change | +$1.42 (+3.06%) | ||
Open | $46.47 | ||
High | $48.00 | ||
Low | $46.08 | ||
Previous Close | $46.47 | ||
Volume | 1,031,864 | ||
30-Day Average Volume | 1,752,321 | ||
1-Week Change | 4.36% | ||
1-Month Change | 17.93% | ||
1-Year Change | 52.49% | ||
3-Year Change | 101.22% | ||
5-Year Change | 95.31% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.4B | ||
Market Cap | $7.9B | ||
Enterprise Value | $8.8B | ||
Period: QTR TTM FY | |||
Revenue | $417.3M | ||
Net Income | $16.3M | ||
Free Cash Flow | $90.1M | ||
EBIT | $14.7M | ||
EBITDA | $41.9M | ||
Net Working Capital | $928.8M | ||
EPS | $0.09 | ||
Enterprise Value/EBITDA | 209 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 4 | ||
P/E | 532 | ||
PEG | N/A | ||
Price/Free Cash Flow | 88 | ||
Price/Operating Cash Flow | 84 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue